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A report on the XXXV International Congress of
Physiological Sciences, held together with Experimental
Biology 2005, San Diego, USA, 31 March - 6 April 2005. 
A massive meeting with an estimated 15,000 delegates and
accompanying persons brought together a world physiology
congress, seven national American learned societies, and a
further 30 guest societies in San Diego in March. The byline
for the meeting was ‘From genomes to functions’, so a high
degree of relevance to genome biology could be hoped for.
The standard of talks in the 1,024 sessions was high, and
many described the use of post-genomic technology in their
work. This was refreshing, given that the disconnect between
genomic technologists and functional biologists, such as
physiologists, is probably the largest obstacle to true func-
tional genomics at present. It was good to see the wide-
spread deployment not only of arrays and proteomics, but
also of comparative genomic approaches to the evolution of
development (evo-devo), together with the use of simpler
model organisms where appropriate.
High-throughput genetics
The most impressive contributions to high-throughput func-
tional genomics came from combined genotype/phenotype
approaches in model organisms. Perhaps unusually for such
meetings, the presidential address by Allen Cowley (Medical
College of Wisconsin, Milwaukee, USA) was the most spec-
tacular research contribution. The premise was simple: to
perform quantitative trait locus (QTL) analysis for heart and
renal phenotypes in wild-type and established mutant rat
strains. The scale of execution is remarkable: essentially a
whole physiology department [http://pga.mcw.edu] has
converted to phenotyping hundreds of thousands of rats in
unprecedented detail (more than 200 traits measured for
each rat, and over a third of a million measurements to
date). The project has already generated interesting results,
for example that most of the hypertension-related traits in
rats are sexually dimorphic. It has also generated valuable
resources, including a collection of rat chromosome substi-
tution strains (CSS, also called ‘consomic’ strains). They are
based on the Dahl salt-sensitive strain; in each line, one
chromosome of the Dahl strain has been individually
replaced (by repeated back-crossing) with the corresponding
chromosome of another strain, BN. Some of these strains are
now available commercially [http://www.criver.com] and
provide a valuable resource for rapid identification of chro-
mosomes carrying a particular genetic trait.
Another example of the heroic use of genetics to provide a
functional analog of high-throughput research is ‘Neuromice’
[http://www.neuromice.org], part of the mouse initiative cur-
rently being carried out with National Institutes of Health
funding [http://www.nih.gov/science/models/mouse]. The
collaboration, described by Joseph Takahashi (Northwestern
University, Evanston, USA), between three mutagenesis
programs - at Northwestern University, the Jackson Lab
(Bar Harbor, USA), and the University of Tennessee
(Knoxville, USA) - is relying on ethylnitrosourea (ENU)
mutagenesis and a three-generation screen to provide a
range of more subtle phenotypes than simple knockouts. Mice
are being screened for a wide range of neural and behavioral
phenotypes at the rate of 10,000 per year (40,000 planned
over 4 years) and 155 strains are searchable online so far. The
phenotypes found to date include circadian defects, circling,
and satiety defects.
Automated screening and tissue harvesting 
Moving to simpler model organisms, Todd Lamitina from
Kevin Strange’s group (Vanderbilt Medical Center,
Nashville, USA) reported the use of the COPAS sorting
system [http://www.unionbio.com] to powerful effect tostudy an osmoregulation phenotype in the nematode
Caenorhabditis elegans. COPAS is effectively a multipara-
meter cell sorter, but can also be used to detect different
phenotypes in whole transgenic organisms, including the
fruitfly Drosophila melanogaster, the zebrafish Danio rerio,
and the cress Arabidopsis thaliana. It is possible to sort not
just on size or fluorescent intensity, but even on the profile
of fluorescence along the length of an organism. Small
organisms can be sorted - live - into multiwell dishes for
further analysis. For traditional ‘forward’ genetics, the
advantage is that a saturating mutagenesis screen can be
performed almost unsupervised. For example, 300,000
ENU-mutant worms were screened for altered expression of
enhanced glycerol dehydrogenase tagged with green fluores-
cent protein (eGFP), indicative of failure to osmoregulate,
and 80 lines were isolated. In a further screen but this time
working ‘in reverse’, from gene to phenotype, worms carrying
a GFP reporter for an osmotically relevant gene were exposed
to the worm RNA interference (RNAi) feeding library and
then screened for suppression of enhancement of fluores-
cence. (The feeding library is a collection of Escherichia
coli containing plasmids expressing RNAi constructs
against virtually the whole predicted worm transcriptome
[http://www.openbiosystems.com/clones_c_elegans_orf.php].)
More than 130,000 worms were screened in a little over a day,
leading again to around 80 genes being implicated as relevant.
It is thus clear that, with a little ingenuity in experimental
design, this equipment allows effectively saturating genetic
screens (forward or reverse) to be performed with great speed.
One of the problems in both proteomics and transcriptomics
is the difficulty of obtaining distinct tissues in sufficient
quantity and purity for useful analysis. R. Lance Miller (Uni-
versity of Utah, Salt Lake City, USA) also reported the use of
COPAS, in this case to select kidney collecting-duct regions
enriched for principal or intercalated cells, based on GFP
reporters driven by aquaporin or V-ATPase promoters,
respectively. The yield obtained by this method was suffi-
cient for proteomic analysis. The average length of collecting
duct regions was 260 µm, and was obtained with good mor-
phological preservation. This technique addresses the
problem of trying to study a compact but immensely
complex tissue like the kidney; such screens could thus be
valuable for a range of physiological, pharmacological or
molecular endpoints.  
Bright prospects in imaging 
Roger Tsien (University of California at San Diego, USA)
and Atsushi Miyawaki (RIKEN Brain Science Institute,
Wako-city, Japan) described novel reporters for imaging in
relation to large-scale screening. Tsien described the re-
engineering of the cameleon series of calcium reporters to
make them brighter, less sensitive to attenuation by endoge-
nous calmodulin and suitable for use as stable reporters for
imaging the endoplasmic reticulum. Lisa Leon Gallegos
(University of California at San Diego) described a new flu-
orescence resonance energy transfer (FRET) reporter
(called CKAR) for protein kinase C (PKC) that enables PKC
activity to be imaged within a cell. Miyawaki revealed a set of
marine photoproteins that switch between two colors upon
exposure to light of a particular wavelength. Subsequent to
the description in 2002 of the original ‘Kaede’ fluorescent
protein from coral, which switches from green to red fluores-
cence under UV or violet light, different proteins have now
been found that can switch reversibly or irreversibly, sug-
gesting applications anywhere from transgenic cell marking
to organic memory for computers. Indeed, the writing lasers
used to switch Kaede proteins from one state to another in
single cells were those from ‘blu-ray’ DVD drives. Kaede
transgenic mice have already been made. 
In the ‘breakthrough technologies’ session, Robi Mitra
(Washington University, St Louis, USA) described progress
in single-molecule DNA sequencing. Typically, single PCR
amplimer molecules are suspended in a gel on a microscope
slide to provide individual PCR colonies (‘polonies’). Incor-
poration of single fluorescently tagged nucleotides is alter-
nated with reading each colony by fluorescence microscopy.
Although the maximum length achievable at present is of the
order of tens of bases, the massive parallelism of the
approach offers potential advantages both for genotyping
and de novo sequencing.
Elsewhere in the genomics track that ran through the meeting,
Hans Westerhoff (Free University, Amsterdam, The Nether-
lands) nicely illustrated the utility of the systems biology
approach in providing models for predicting cellular
functions, currently being developed in the ‘silicon cell’. He
was able to illustrate that by integrating separate models into
systems-level analysis, predictions could be made that are suf-
ficiently counterintuitive that they would not have been
arrived at by human insight alone. As well as describing work
modeling yeast cell behavior, he showed that critical steps for
pharmacological intervention could be predicted by this
approach, for example in the parasite Trypanosoma brucei.
Several other speakers clearly had an eye on the transition to
systems biology. The need to produce models in an integrat-
able, generic form was highlighted by Poul Nielsen (University
of Auckland, New Zealand), who discussed the development of
the language CellML, based on the XML markup language, for
the description of biological models [http://www.cellml.org].
Mike Cherry (Stanford University, USA) illustrated the
progress made in improving the already excellent annotation
of the yeast genome [http://www.yeastgenome.org], by com-
paring yeast sequence with shotgun sequences of a range of
related species. A large number of ATG sites had been reas-
signed, and 800 genes from the original annotation had been
reassigned as dubious. Improved links to gene ontology, and
to pathway tools such as Peter Karp’s collection of
pathway/genome databases [http://www.biocyc.org], were
also continuing to add utility to the yeast sequence. 
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Genome Biology 2005, 6:335Back in humans, Kelly Frazer (Perlegen Sciences, Inc.,
Mountain View, USA), described the use of biochips for
detecting single-nucleotide polymorphisms (SNPs) to look at
differential expression of the two haplotypes for each gene.
Such differential expression had been thought to be the
property of relatively few imprinted genes, but a systematic
analysis of several thousand genes suggests that as many as
20% of human genes might be differentially expressed in
any individual, and that this percentage varies widely
between individuals. The implications for pharmacoge-
nomics - the tailoring of drugs to the individual patient - are
obvious. Eric Green (National Human Genome Research
Institute, Bethesda, USA) described the ENCODE project
[http://www.nisc.nih.gov/open_page.html?/projects/encode/
index.cgi], which seeks to identify all the functional elements
in the human genome by massive parallel sequencing of
related species. The project has provided evidence that it is
possible to delineate not just the 1.5% of the human genome
that is protein coding, but a further 3.5% that is non-coding
but still under selection.
Overall, the meeting provided clear evidence that functional
biology is not just exploiting, but adding value to, post-
genomic endeavor.
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